Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
02/2007
02/15/2007US20070037807 Pyridine compounds as inhibitors of dipeptidyl peptidase IV
02/15/2007US20070037795 2-methyl-1-[2-(4-nitrophenoxy)-ethyl]-1,2,3,4-tetrahydroisoquinolin-6-yl dimethylcarbamate; Acetylcholinesterase inhibitors; selective serotonin reuptake inhibitory; Alzheimer's disease, depression, Huntington's chorea, Pick's disease, tardive dyskinesia, compulsive disorders or panic disorders
02/15/2007US20070037793 2-methyl-1-[2-(4-nitrophenoxy)-ethyl]-1,2,3,4-tetrahydroisoquinolin-6-yl dimethylcarbamate; Acetylcholinesterase inhibitors; selective serotonin reuptake inhibitory; Alzheimer's disease, depression, Huntington's chorea, Pick's disease, tardive dyskinesia, compulsive disorders or panic disorders
02/15/2007US20070037785 Novel dipeptidyl peptidase IV inhibitors used for functionally influencing different cells and treating immunological, infammatory, neuronal, and other diseases
02/15/2007CA2618486A1 Ep2 receptor agonists
02/15/2007CA2618481A1 Compounds for treating alzheimer's disease
02/15/2007CA2618474A1 Compounds for treating alzheimer's disease
02/15/2007CA2618112A1 Pyridone compound
02/15/2007CA2618019A1 Compounds for the treatment of alzheimer's disease
02/15/2007CA2618013A1 Beta-secretase inhibitors for use in the treatment of alzheimer's disease
02/15/2007CA2617703A1 Androgen modulators
02/15/2007CA2617293A1 7-substituted aza-indazoles, compositions containing same, production method and use thereof
02/15/2007CA2616249A1 A process for the preparation of substituted phenyl ether compounds and rosiglitazone
02/15/2007CA2614857A1 Substance having antioxidant, geroprotective and anti-ischemic activity and method for the preparation thereof
02/14/2007EP1752455A2 Chemokine receptor binding heterocyclic compounds
02/14/2007EP1751136A2 Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer
02/14/2007EP1751115A1 Theramutein modulators
02/14/2007EP1751113A1 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
02/14/2007EP1751110A1 Method for the production of a-chloroalkylpyridyl ketones and/or the hydrochlorides thereof
02/14/2007EP1751109A1 Fungicidal composition comprising a pyridylethylbenzamide derivative and a compound capable of inhibiting the transport of electrons of the respiratory chain in phytopathogenic fungal organisms
02/14/2007EP1751108A1 Adamantyl-acetamide derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
02/14/2007EP1751091A2 2-amino- and 2-thio-substituted 1,3-diaminopropanes
02/14/2007EP1751087A1 Levodopa prodrugs, and compositions and uses thereof
02/14/2007EP1670743B1 Production process of optically pure 2-(4-hydroxyphenoxy)-propionic acid compounds
02/14/2007EP1603876B1 Process for the preparation of pyridinyl and pyrimidinyl mono-fluorinated beta keto esters
02/14/2007EP1533292B1 Dibenzylamine compound and medicinal use thereof
02/14/2007EP1456174B1 Pyridyloxyalkanoic acid amide derivatives useful as fungicides
02/14/2007EP1339701B1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors
02/14/2007CN1914196A 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratiory syncytial virus replication
02/14/2007CN1914184A Urea derivatives
02/14/2007CN1913880A Method for treating ADAMTS-5-associated disease
02/14/2007CN1300114C Phenylpyridine carbonyl piperazine derivative
02/14/2007CN1300113C Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors
02/14/2007CN1299777C Stilbene derivatives and their use for binding and imaging amyloid plaques
02/13/2007US7176311 Process for preparing pharmaceutically active compounds
02/13/2007US7176307 Group 9 or 10 metal complexes of N-(N-heterocycle-substuted)acridines, phenoxazines and phenothiazines that are capable of converting a triplet excitation state into light emission and excellent in heat resistance; electronic devices with low power consumption
02/13/2007US7176306 Hydroxyalkyl cyclic diamine compound
02/13/2007US7176255 Emulsion polymerized colored addition polymers using an oil in water emulsion containing in the dispersed phase and oil-soluble unsaturated dye in droplet form having diameters of dz < 1000; whiteness requires a much lower amount of water-soluble optical brightener in the case of paper coating slips
02/13/2007US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
02/13/2007US7176241 Aromatic or heteroaromatic compounds containing amide group are useful as inhibitor of dihydroorotate dehydrogenase
02/13/2007US7176240 Such as 5-fluoro-2-propylpentanoic acid for improving GABA (gamma-aminobutyric acid) receptor responses; treatment of neurodegenerative diseases
02/13/2007US7176228 Amidobiphenyloxime derivatives, useful as fungicide or bactericide for protection of crops and materials
02/13/2007US7176223 5-(3-Pyridylmethyl)imidazolidine-2,4-dione is subjected to a hydrolysis reaction, wherein the reaction is followed by a decarbamation reaction to obtain (3-pyridyl)alanine
02/13/2007US7176214 Imidazo-fused oxazolo[4,5-β]pyridine and imidazo-fused thiazolo[4,5-β]pyridine based tricyclic compounds and pharmaceutical compositions comprising same
02/13/2007US7176204 Substituted carboxylic acid derivatives
02/13/2007US7175872 Food sweetness or saltiness enhancers; such as N(1-carboxyethyl)-6-hydroxymethyl-pyridinium-3-olate; synthesis from amino acid or peptide with furan derivative
02/13/2007US7175670 And an oxidation base; couplers such as N-(3,5-diaminopyrid-2-yl)pyrrolidine; strong, uniform dyeing results between the end and the root, resistant to external agents, capable of giving varied shades
02/13/2007CA2359510C .omega.-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
02/13/2007CA2112420C N-arylhydrazine derivatives as insecticidal and acaricidal agents
02/08/2007WO2007015767A1 Pyridine derivatives as dipeptedyl peptidase inhibitors
02/08/2007WO2007015536A1 Compound, photoelectric transducer and photoelectrochemical cell
02/08/2007WO2007015533A1 Amidine compound and herbicide
02/08/2007WO2007015312A1 Polyacrylamide gel for electrophoresis, polyacrylamide gel electrophoresis method using the same, method of producing the same and acrylamide compound
02/08/2007WO2007014913A1 Cyanopyridine pesticides
02/08/2007WO2007014607A1 Quadratic acid derivatives in the form of a protein kinase inhibitors
02/08/2007WO2006123229A3 Novel heterocyclic derivatives
02/08/2007WO2006110477A3 Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus
02/08/2007WO2006063010A3 Compounds and methods of use thereof
02/08/2007US20070032658 Reacting an N-protected diphenylalanine with an optically active 1-phenyl- or 1-naphthyl-ethylamine and separating (crystal precipitation) the resulting diastereomeric salt; converting to free acid; deprotecting; synthetic intermediate for anti-HIV drugs and dipeptidyl peptidase inhibitors
02/08/2007US20070032657 Method of preparation of nitroaminopyridine compounds
02/08/2007US20070032532 Hsp90 family protein inhibitors
02/08/2007US20070032500 Therapeutic agents useful for treating pain
02/08/2007US20070032489 Substituted pyridones as inhibitors of poly(adp-ribose) polymerase (parp)
02/08/2007US20070032474 Use of a compound of formula 1 for making a pharmaceutical composition
02/08/2007US20070029520 Benzene Derivative Having Long, Linear Conjugated Structure, Process For Producing Benzene Derivative, And Liquid-Crystal Material
02/08/2007DE102005035741A1 Quadratsäurederivate Squaric acid derivatives
02/08/2007DE102005035103A1 Producing onium tetrafluoroborates useful as ionic liquids comprises reacting an onium halide with a trialkyloxonium, trialkylsulfonium or triphenylcarbonium tetrafluoroborate
02/08/2007CA2617413A1 2-aminoaryl pyridines as protein kinases inhibitors
02/08/2007CA2616682A1 Squaric acid derivatives as protein kinase inhibitors
02/07/2007EP1749516A2 Lock and key micelles
02/07/2007EP1748989A2 Aryl sulfonamides
02/07/2007EP1748987A2 2-propene-1-ones as hsp 70 inducers
02/07/2007EP1748986A2 Heterocyclic compounds and their use as aldosterone synthase inhibitors
02/07/2007EP1626716B1 Nitrooxyderivatives of fluvastatin, pravastatin, cerivastatin, atorvastatin and rosuvastatin as cholesterol-reducing agents with improved anti-inflammatory, antithrombotic and antiplatelet activity
02/07/2007EP1315501B1 Alpha v integrin receptor antagonists
02/07/2007EP1261336B1 Il-8 receptor antagonists
02/07/2007CN1910310A DAST twin crystal, process for producing the same and use thereof
02/07/2007CN1910176A Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
02/07/2007CN1910175A 组织蛋白酶半胱氨酸蛋白酶抑制剂 Cathepsin cystatin
02/07/2007CN1910173A Indolylmaleimide derivatives as PKC inhibitors
02/07/2007CN1910166A Heteroaryl-ureas and their use as glucokinase activators
02/07/2007CN1910153A Derivatives of pyridine and quinoline
02/07/2007CN1910152A Process for the manufacture of 2,3-dichloropyridine
02/07/2007CN1910141A Diamino alcohols and their use as renin inhibitors
02/07/2007CN1907972A Process for preparing 2,3,5,6-tetraaminopyridine
02/07/2007CN1907971A Ciclopirox olamine crystal and method for preparing the same
02/07/2007CN1907970A Method for synthesizing heteroaryl thiosemicarbazone antineoplastic
02/07/2007CN1907969A Benzoylpyridine derivative or its salt, disinfectant containing the same as active ingredient method for producing the same and intermediate for producing the same
02/07/2007CN1298706C Insecticidal diamides
02/06/2007US7173154 Transfection reagents
02/06/2007US7173130 Detection of transmembrane potentials by optical methods
02/06/2007US7173025 Compounds for use as anticoagulants for treatment of arteries in brains and factor x inhibitors
02/06/2007US7172769 Methylsulfonylphenyl or phenylsulfonamide derivatives having ring selected from cyclopentenone, furanone, methylpyrazole, isoxazole and pyridine; celecoxib and rofecoxib; administered for pain; oral drug delivery
02/06/2007CA2411961C Novel process for the preparation of pyrazolopyrimidinones
02/06/2007CA2362816C Valdecoxib compositions
02/06/2007CA2307195C Method for producing isoureas
02/01/2007WO2007013830A1 Nitrocatechol derivatives as comt inhibitors
02/01/2007WO2007013694A1 Phenoxyalkanoic acid compound
02/01/2007WO2007012762A1 Novel polysubstituted 1,1-pyridinyloxycyclopropanamine compounds, method for preparing same and pharmaceutical compositions containing same
02/01/2007WO2007012761A1 Novel polysubstituted 1,1-pyridinyl aminocyclopropanamine derivatives, method for preparing same and pharmaceutical compositions containing same